title: p27 as a target for cancer therapeutics.
authors.affiliation: Department of Cell Biology and Genetics, Memorial Sloan-Kettering Cancer Institute, 1275 York Avenue, New York, NY 10021, USA. stacy.blain@downstate.edu
authors.forename: Stacy W
authors.initials: SW
authors.lastname: Blain
authors.forename: Howard I
authors.initials: HI
authors.lastname: Scher
authors.forename: Carlos
authors.initials: C
authors.lastname: Cordon-Cardo
authors.forename: Andrew
authors.initials: A
authors.lastname: Koff
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D018797:Cell Cycle Proteins / Q000037:antagonists & inhibitors*; D050760:Cyclin-Dependent Kinase Inhibitor p27; D018844:Cyclin-Dependent Kinases / Q000037:antagonists & inhibitors; D016147:Genes, Tumor Suppressor; D006801:Humans; D051379:Mice; D018345:Mice, Knockout; D009369:Neoplasms / Q000201:enzymology / Q000473:pathology / Q000628:therapy*; D025521:Tumor Suppressor Proteins / Q000037:antagonists & inhibitors*
chemical_list: D000970:Antineoplastic Agents; C493961:Cdkn1b protein, mouse; D018797:Cell Cycle Proteins; D025521:Tumor Suppressor Proteins; D050760:Cyclin-Dependent Kinase Inhibitor p27; D018844:Cyclin-Dependent Kinases